This paper introduces a novel cardiosynchronized device for extracorporeal and intracorporeal circulatory support during intensive cardiac failure therapy. Prototype testing indicates its clinical utility and readiness for scaled production.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: